Delcath Systems, Inc. (DCTH) Financial Statements (2024 and earlier)

Company Profile

Business Address 1633 BROADWAY
NEW YORK, NY 10019
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7,67122,80228,57510,0022,5163,999
Cash and cash equivalents7,67122,80228,57510,0022,5163,999
Restricted cash and investments4,1514,1511811811,0621,325
Receivables366445721585317
Inventory, net of allowances, customer advances and progress billings1,9981,4128556548581,248
Inventory1,9981,4128556548581,248
Prepaid expense2181,1131,173952268580
Other undisclosed current assets1,7511,6301,497807630120
Total current assets:16,15531,15232,33812,6175,9197,589
Noncurrent Assets
Operating lease, right-of-use asset285624946860
Property, plant and equipment1,4221,3481,3517359251,298
Total noncurrent assets:1,7071,9722,2971,5959251,298
TOTAL ASSETS:17,86233,12434,63514,2126,8448,887
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6,7034,7477,01511,48015,6797,254
Accounts payable2,0186381,7744,5337,7153,846
Accrued liabilities4,6854,1095,2416,9477,9643,408
Deferred revenue  170525 
Debt7,8466212,0006642,038 
Derivative instruments and hedges, liabilities    3,36833560
Other undisclosed current liabilities186416495   
Total current liabilities:14,7355,95410,03515,51217,7507,814
Noncurrent Liabilities
Long-term debt and lease obligation7,84215,2184502,197  
Long-term debt, excluding current maturities7,84215,011 2,000  
Liabilities, other than long-term debt1,144 2,0722,860628395
Deferred revenue   2,0722,860
Other liabilities1,144   628395
Operating lease, liability  207450197
Derivative instruments and hedges, liabilities      
Other undisclosed noncurrent liabilities  (207)  3,405 
Total noncurrent liabilities:8,98615,2182,5225,0574,033395
Total liabilities:23,72121,17212,55720,56921,7838,209
Equity
Equity, attributable to parent(5,859)11,95222,078(6,357)(14,939)678
Common stock100796011031,141
Treasury stock, value      (51)
Additional paid in capital451,608432,831417,449364,785328,962324,378
Accumulated other comprehensive income (loss)(83)18(104)285042
Accumulated deficit(457,484)(420,976)(395,327)(371,171)(344,054)(324,832)
Total equity:(5,859)11,95222,078(6,357)(14,939)678
TOTAL LIABILITIES AND EQUITY:17,86233,12434,63514,2126,8448,887

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues2,719132206390 2,715
Revenue, net2,715
Sublease income  132206390
Cost of revenue(686)(671)(640)(719)(1,009)(701)
Other undisclosed gross profit 3,4231,4401,1903,407 
Gross profit:2,0332,8841,0068612,3982,014
Operating expenses(35,886)(27,415)(22,309)(20,769)(29,469)(20,179)
Operating loss:(33,853)(24,531)(21,303)(19,908)(27,071)(18,165)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
3068154251(41)
Interest and debt expense(1,900)(675) (1,720)(2,826)(12,090)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes   (3,007)12,74710,624(14,821)
Loss from continuing operations before equity method investments, income taxes:(35,723)(25,138)(24,156)(8,879)(19,222)(45,117)
Other undisclosed loss from continuing operations before income taxes(784)(511)    
Loss from continuing operations:(36,507)(25,649)(24,156)(8,879)(19,222)(45,117)
Loss before gain (loss) on sale of properties:(25,649)(24,156)(8,879)(19,222)(45,117)
Net loss:(36,507)(25,649)(24,156)(8,879)(19,222)(45,117)
Net loss attributable to noncontrolling interest   (24,211)   
Other undisclosed net income (loss) attributable to parent(1) 24,211   
Net loss attributable to parent:(36,508)(25,649)(24,156)(8,879)(19,222)(45,117)
Other undisclosed net loss available to common stockholders, basic      (527)
Net loss available to common stockholders, diluted:(36,508)(25,649)(24,156)(8,879)(19,222)(45,644)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(36,507)(25,649)(24,156)(8,879)(19,222)(45,117)
Comprehensive loss:(36,507)(25,649)(24,156)(8,879)(19,222)(45,117)
Comprehensive loss, net of tax, attributable to noncontrolling interest   (24,211)   
Other undisclosed comprehensive income (loss), net of tax, attributable to parent10012224,079(22)883
Comprehensive loss, net of tax, attributable to parent:(36,407)(25,527)(24,288)(8,901)(19,214)(45,034)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: